Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Stock Movers: Synaptics, Lumentum, Acadia Pharma
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies making news on Wall Street. Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for…
A Big Pharma Executive Is Jumping to Nike-and Critics Are Already Questioning the Move
A sportswear giant is making key leadership changes. Nike recently announced that Pfizer executive David Denton will take over as its chief financial officer later this summer. The news comes shortly after Pfizer announced Denton would be stepping…
Why Is Shuttle Pharma Stock Gaining Friday? - Shuttle Pharmaceuticals (NASDAQ:SHPH)
The company said it is assessing behind-the-meter power generation assets in Idaho and Alberta as part of a strategy aimed at lowering operating costs and increasing flexibility for its growing mining business. United Dogecoin said the initiative…
Government proposes simplified drug import rules to boost pharma R&D
In a significant step towards promoting research and innovation and enhancing ease of doing business in the pharmaceutical sector, the Union Ministry of Health and Family Welfare has proposed amendments to the Drugs Rules, 1945, to simplify the…
Zydus Lifesciences, Sunshine Healthcare form $20 million JV to set up pharma manufacturing facility in Sri Lanka
Zydus Lifesciences and Sri Lanka's Sunshine Healthcare have formed a joint venture to establish a pharmaceutical manufacturing facility in Sri Lanka with an investment commitment of over $20 million, as the island nation looks to strengthen…
'Grave allegations': Gurgaon court denies bail to fake Mounjaro racket mastermind
4 min read Gurgaon Make us preferred source on Google A city court has recently dismissed the regular bail application of Avi Sharma, the alleged mastermind behind the fake weight-loss drug Mounjaro injection racket case. Rejecting the bail plea…
Novo Nordisk: 3 Key Reasons The 'Buy The Dip' Thesis Is Flawed (NYSE:NVO)
Novo Nordisk A/S faces a complex outlook as GLP-1 market leadership is challenged by intensifying competition and pricing pressures. NVO's 2026 guidance forecasts a 4–12% decline in revenues and operating profit, driven by lower realized…
A Breakthrough-Designated Depression Drug Is 86% Through Its Phase 3, With Topline Data Due This Year
Issued on behalf of Helus Pharma™ Helus Pharma™ (NASDAQ: HELP) (Cboe CA: HELP), the commercial operating name of Cybin Inc., says its APPROACH Phase 3 trial of HLP003 for adjunctive treatment of major depressive disorder has surpassed…
Help reimagine health care for Oregonians and all
As America prepares to celebrate our 250th anniversary, a more recent but disturbing anniversary looms large for millions of families in Oregon and nationwide. On July 4th, 2025, congressional Republicans passed their so-called One, Big, Beautiful…
Snap's Specs Gamble
In this episode of Motley Fool Hidden Gems Investing, Motley Fool contributors Travis Hoium, Lou Whiteman, and Rachel Warren discuss: Snap's new Specs. Rivian announces more layoffs. Eli Lilly's acquisition spree continues. To catch full episodes…
Dyne Therapeutics vs. Viking Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?
High-stakes clinical trials define the 2026 landscape for Dyne Therapeutics (DYN +4.34%) and Viking Therapeutics (VKTX +3.79%). Both firms seek to revolutionize patient care while navigating the complex path toward regulatory approval. Dyne targets…
Product recalls in June 2026, sand toys, blood pressure meds and donuts affected
Supermarket shoppers are urged to check their homes for recalled products announced this month. A mixture of medical and culinary recalls, not to mention asbestos traces in children's sand kits. The recalls are imposed as the products could cause…
Spinal Muscular Atrophy drug: regulatory approval should guide Kerala's procurement policy, say experts
The treatment of Spinal Muscular Atrophy (SMA), a rare progressive genetic disorder that destroys motor neurons and weakens muscles, leading to severe disability and sometimes, premature death, is emerging as a contentious issue in Kerala. Kerala…
Why Acadia Pharmaceuticals Stock Is Soaring Today
Already recovering from weakness suffered early this year, Acadia Pharmaceuticals (ACAD +11.00%) shares were outright catapulted higher today. Indeed, the pharmaceutical stock's 12.2% gain as of 12:17 p.m. ET Friday has pushed it back within sight…
Lupin Receives Tentative Approval from U.S. FDA for Enzalutamide Tablets
MUMBAI, India and NAPLES, Fla., June 26, 2026 /CNW/ -- Global pharmaceutical leader Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced that it has received tentative approval from the United…
Receive a Daily briefing on Pharma Industry News
Get Started